Dopamine Dysregulation in Reward and Autism Spectrum Disorder
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Autism spectrum disorder (ASD) is primarily characterized by core deficits in social skills, communication, and cognition and by repetitive stereotyped behaviors. These manifestations are variable between individuals, and ASD pathogenesis is complex, with over a thousand implicated genes, many epigenetic factors, and multiple environmental influences. The mesolimbic dopamine (DA) mediated brain reward system is held to play a key role, but the rapidly expanding literature reveals intricate, nuanced signaling involving a wide array of mesolimbic loci, neurotransmitters and receptor subtypes, and neuronal variants. How altered DA signaling may constitute a downstream convergence of the manifold causal origins of ASD is not well understood. A clear working framework of ASD pathogenesis may help delineate common stages and potential diagnostic and interventional opportunities. Hence, we summarize the known natural history of ASD in the context of emerging data and perspectives to update ASD reward signaling. Then, against this backdrop, we proffer a provisional framework that organizes ASD pathogenesis into successive levels, including (1) genetic and epigenetic changes, (2) disrupted mesolimbic reward signaling pathways, (3) dysregulated neurotransmitter/DA signaling, and finally, (4) altered neurocognitive and social behavior and possible antagonist/agonist based ASD interventions. This subdivision of ASD into a logical progression of potentially addressable parts may help facilitate the rational formulation of diagnostics and targeted treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Lastly, alterations in dopaminergic signaling in the PFC are further known to result in changed social behavior and social recognition in ASD-associated animal models [101, 102].”
From Behavioral phenotyping identifies autism-like repetitive stereotypies in a Tsc2 haploinsufficient rat model (2025) · cites this paper as [101]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global prevalence of autism: A systematic review update
Zeidan, J., Fombonne, E., Scorah, J., Ibrahim, A., Durkin, M. S., Saxena, S., Yusuf, A., Shih, A., & Elsabbagh, M. (2022) · Autism Research · doi:10.1002/aur.2696 · Cited by 3,117
Model of autism: increased ratio of excitation/inhibition in key neural systems
Rubenstein, J. L. R., & Merzenich, M. M. (2003) · Genes, Brain and Behavior · doi:10.1034/j.1601-183x.2003.00037.x · Cited by 2,768 · cited 2×
“Mesolimbic DAergic reward signaling is thought to be impacted by disrupted brain excitatory–inhibitory (E/I) balance, and moreover, this equilibrium is held to be regulatory in autistic subjects [19,108].”
BackgroundAutism as a strongly genetic disorder: evidence from a British twin study
Bailey, A., Le Couteur, A., Gottesman, I., Bolton, P., Simonoff, E., Yuzda, E., & Rutter, M. (1995) · Psychological Medicine · doi:10.1017/s0033291700028099 · Cited by 2,461 · cited 1×
“Ample data suggest that there is a genetic basis for ASD, and it is frequently noted that studies of families and twins have provided data pointing to a genetic component of ASD [19,28,29].”
BackgroundThe social motivation theory of autism
Chevallier, C., Kohls, G., Troiani, V., Brodkin, E. S., & Schultz, R. T. (2012) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2012.02.007 · Cited by 2,072 · cited 3×
“…are three key processes: (1) social orienting, which includes attention to faces, social signals, and eye contact; (2) seeking–liking, which refers to the incentive value, i.e., wanting and liking of social reward stimuli; and (3) social maintaining, which includes ingratiation strategies [22].”
BackgroundInfluentialDalgleish, T. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1432 · Cited by 1,849
Molecular diversity and specializations among the cells of the adult mouse brain
Saunders, A., Macosko, E. Z., Wysoker, A., Goldman, M., Krienen, F. M., de Rivera, H., Bien, E., Baum, M., Bortolin, L., Wang, S., et al. (2018) · Cell · doi:10.1016/j.cell.2018.07.028 · Cited by 1,531
Amaral, D. G., Schumann, C. M., & Nordahl, C. W. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2007.12.005 · Cited by 1,492 · cited 1×
“The basolateral amygdala (BLA) is widely thought to play a role in ASD; it communicates bi-directionally with the nucleus accumbens (NAc), a key reward locus, and principal BLA neurons receive glu-taminergic, DAergic, and GABAergic inputs [138,139].”
BackgroundThe mysterious motivational functions of mesolimbic dopamine
Salamone, J. D., & Correa, M. (2012) · Neuron · doi:10.1016/j.neuron.2012.10.021 · Cited by 1,418 · cited 1×
“…this is a simplified portrayal; in fact, the mesolimbic DA system is much more nuanced and is involved with aversive motivational processes, including behavioral activation, exertion of effort, approach behavior, sustained task engagement, Pavlovian processes, and instrumental learning [122].”
BackgroundThe Role of the Dorsal Striatum in Reward and Decision-Making: Figure 1.
Balleine, B. W., Delgado, M. R., & Hikosaka, O. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1554-07.2007 · Cited by 1,390
Prenatal Valproate Exposure and Risk of Autism Spectrum Disorders and Childhood Autism
Christensen, J., Grønborg, T. K., Sørensen, M. J., Schendel, D., Parner, E. T., Pedersen, L. H., & Vestergaard, M. (2013) · JAMA · doi:10.1001/jama.2013.2270 · Cited by 1,357
Research works printed but not linked: 134
- 2017, A Dopamine Hypothesis of Autism Spectrum Disorder, Dev. Neurosci., 39, 355, 10.1159/000478725 · DOI · Paper page
- Baio, 2018, Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years—Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2014, Surveill. Summ., 67, 1, 10.15585/mmwr.ss6706a1 · DOI · Paper page
- Schalbroeck, 2021, Striatal dopamine synthesis capacity in autism spectrum disorder and its relation with social defeat: An [18F]-FDOPA PET/CT study, Transl. Psychiatry, 11, 47, 10.1038/s41398-020-01174-w · DOI
- Salama, 2014, Orquestic regulation of neurotransmitters on reward-seeking behavior, Int. Arch. Med., 7, 29, 10.1186/1755-7682-7-29 · DOI
- Baik, 2020, Stress and the dopaminergic reward system, Exp. Mol. Med., 52, 1879, 10.1038/s12276-020-00532-4 · DOI · Paper page
- Mineur, 2019, The role of acetylcholine in negative encoding bias: Too much of a good thing?, Eur. J. Neurosci., 53, 114, 10.1111/ejn.14641 · DOI · Paper page
- Coddington, 2023, Mesolimbic dopamine adapts the rate of learning from action, Nature, 614, 294, 10.1038/s41586-022-05614-z · DOI · Paper page
- Dunigan, 2022, Actions of feeding-related peptides on the mesolimbic dopamine system in regulation of natural and drug rewards, Addict. Neurosci., 2, 100011, 10.1016/j.addicn.2022.100011 · DOI
- Peters, 2021, Modulating the Neuromodulators: Dopamine, Serotonin, and the Endocannabinoid System, Trends Neurosci., 44, 464, 10.1016/j.tins.2021.02.001 · DOI · Paper page
- Paval, 2023, The dopamine hypothesis of autism spectrum disorder: A comprehensive analysis of the evidence, Int. Rev. Neurobiol., 173, 1, 10.1016/bs.irn.2023.08.009 · DOI
- Kohls, 2011, Atypical Brain Responses to Reward Cues in Autism as Revealed by Event-Related Potentials: A Systematic Review and Meta-analysis, J. Autism Dev. Disord., 41, 1523, 10.1007/s10803-011-1177-1 · DOI · Paper page
- Matyjek, 2023, Reward responsiveness in autism and autistic traits—Evidence from neuronal, autonomic, and behavioural levels, NeuroImage Clin., 38, 103442, 10.1016/j.nicl.2023.103442 · DOI
- Mandic-Maravic, V., Grujicic, R., Milutinovic, L., Munjiza-Jovanovic, A., and Pejovic-Milovancevic, M. (2022). Dopamine in Autism Spectrum Disorders—Focus on D2/D3 Partial Agonists and Their Possible Use in Treatment. Front. Psychiatry, 12. · DOI
- DiCarlo, G.E., and Wallace, M.T. (2021). Modeling dopamine dysfunction in autism spectrum disorder: From invertebrates to vertebrates. Neurosci. Biobehav. Rev., 133. · DOI · Paper page
- Horder, 2018, Glutamate and GABA in autism spectrum disorder—A translational magnetic resonance spectroscopy study in man and rodent models, Transl. Psychiatry, 8, 106, 10.1038/s41398-018-0155-1 · DOI · Paper page
- Whalley, 2011, Converging pathways, Nat. Rev. Neurosci., 12, 372, 10.1038/nrn3062 · DOI
- Mahony, C., and O’Ryan, C. (2022). A molecular framework for autistic experiences: Mitochondrial allostatic load as a mediator between autism and psychopathology. Front. Psychiatry, 13. · DOI
- Jiang, 2022, Signalling pathways in autism spectrum disorder: Mechanisms and therapeutic implications, Signal Transduct. Target. Ther., 7, 229, 10.1038/s41392-022-01081-0 · DOI · Paper page
- Port, R.G., Gandal, M.J., Roberts, T.P.L., Siegel, S.J., and Carlson, G.C. (2014). Convergence of circuit dysfunction in ASD: A common bridge between diverse genetic and environmental risk factors and common clinical electrophysiology. Front. Cell. Neurosci., 8. · DOI
- Supekar, 2018, Deficits in mesolimbic reward pathway underlie social interaction impairments in children with autism: A journal of neurology, Brain, 141, 2795
- Fernandez, 2017, Syndromic autism spectrum disorders: Moving from a clinically defined to a molecularly defined approach, Dialog- Clin. Neurosci., 19, 353, 10.31887/DCNS.2017.19.4/sscherer · DOI · Paper page
- Rodriguez-Gomez, D.A., Garcia-Guaqueta, D.P., Charry-Sánchez, J.D., Sarquis-Buitrago, E., Blanco, M., Velez-Van-Meerbeke, A., and Talero-Gutiérrez, C. (2021). A systematic review of common genetic variation and biological pathways in autism spectrum disorder. BMC Neurosci., 22. · DOI
- Salem, 2013, Genetic variants of neurotransmitter-related genes and miRNAs in Egyptian autistic patients, Sci. World J., 2013, 670621, 10.1155/2013/670621 · DOI
- Sun, 2020, Large-scale mapping of cortical alterations in 22q11.2 deletion syndrome: Convergence with idiopathic psychosis and effects of deletion size, Mol. Psychiatry, 25, 1822, 10.1038/s41380-018-0078-5 · DOI · Paper page
- Ho, K.S., Wassman, E.R., Baxter, A.L., Hensel, C.H., Martin, M.M., Prasad, A., Twede, H., Vanzo, R.J., and Butler, M.G. (2016). Chromosomal Microarray Analysis of Consecutive Individuals with Autism Spectrum Disorders Using an Ultra-High Resolution Chromosomal Microarray Optimized for Neurodevelopmental Disorders. Int. J. Mol. Sci., 17. · DOI
- Ousley, O., Evans, A.N., Fernandez-Carriba, S., Smearman, E.L., Rockers, K., Morrier, M.J., Evans, D.W., Coleman, K., and Cubells, J. (2017). Examining the Overlap between Autism Spectrum Disorder and 22q11.2 Deletion Syndrome. Int. J. Mol. Sci., 18. · DOI
- Michaelovsky, E., Frisch, A., Carmel, M., Patya, M., Zarchi, O., Green, T., Basel-Vanagaite, L., Weizman, A., and Gothelf, D. (2012). Genotype-phenotype correlation in 22q11.2 deletion syndrome. BMC Med. Genet., 13. · DOI · Paper page
- Grandy, 1989, Cloning of the cDNA and gene for a human D2 dopamine receptor, Proc. Natl. Acad. Sci. USA, 86, 9762, 10.1073/pnas.86.24.9762 · DOI · Paper page
- Grandy, 1989, The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP, Am. J. Hum. Genet., 45, 778
- Ariza, M., Garolera, M., Jurado, M.A., Garcia-Garcia, I., Hernan, I., Sánchez-Garre, C., Vernet-Vernet, M., Sender-Palacios, M.J., Marques-Iturria, I., and Pueyo, R. (2012). Dopamine genes (DRD2/ANKK1-TaqA1 and DRD4-7R) and executive function: Their interaction with obesity. PLoS ONE, 7. · DOI
- Berlin, 2000, Dopaminergic drug response and the genotype (Taq IA polymorphism) of the dopamine D2 receptor, Int. J. Neuropsychopharmacol., 3, 35, 10.1017/S1461145700001711 · DOI
- Suzuki, 2009, Sept5 deficiency exerts pleiotropic influence on affective behaviors and cognitive functions in mice, Hum. Mol. Genet., 18, 1652, 10.1093/hmg/ddp086 · DOI
- Zhao, F., Zhang, H., Wang, P., Cui, W., Xu, K., Chen, D., Hu, M., Li, Z., Geng, X., and Wei, S. (2022). Oxytocin and serotonin in the modulation of neural function: Neurobiological underpinnings of autism-related behavior. Front. Neurosci., 16. · DOI
- Molosh, 2014, Social learning and amygdala disruptions in Nf1 mice are rescued by blocking p21-activated kinase, Nat. Neurosci., 17, 1583, 10.1038/nn.3822 · DOI
- Williams, 2022, Future Prospects for Epigenetics in Autism Spectrum Disorder, Mol. Diagn. Ther., 26, 569, 10.1007/s40291-022-00608-z · DOI
- Eshraghi, A.A., Liu, G., Kay, S.-I.S., Eshraghi, R.S., Mittal, J., Moshiree, B., and Mittal, R. (2018). Epigenetics and Autism Spectrum Disorder: Is There a Correlation?. Front. Cell. Neurosci., 12. · DOI
- Breton, C.V., Landon, R., Kahn, L.G., Enlow, M.B., Peterson, A.K., Bastain, T., Braun, J., Comstock, S.S., Duarte, C.S., and Hipwell, A. (2021). Exploring the evidence for epigenetic regulation of environmental influences on child health across generations. Commun. Biol., 4. · DOI · Paper page
- Tsujimura, K., Shiohama, T., and Takahashi, E. (2022). microRNA Biology on Brain Development and Neuroimaging Approach. Brain Sci., 12. · DOI
- Vella, M.C., and Slack, F.J.C. (2005). elegans microRNAs. WormBook. · DOI
- Yoon, 2018, Epigenetics and epitranscriptomics in temporal patterning of cortical neural progenitor competence, J. Cell Biol., 217, 1901, 10.1083/jcb.201802117 · DOI · Paper page
- Zhao, H., Mao, X., Zhu, C., Zou, X., Peng, F., Yang, W., Li, B., Li, G., Ge, T., and Cui, R. (2022). GABAergic System Dysfunction in Autism Spectrum Disorders. Front. Cell Dev. Biol., 9. · DOI · Paper page
- Loke, Y.J., Hannan, A.J., and Craig, J.M. (2015). The Role of Epigenetic Change in Autism Spectrum Disorders. Front. Neurol., 6. · DOI · Paper page
- Yip, 2009, Decreased GAD65 mRNA levels in select subpopulations of neurons in the cerebellar dentate nuclei in autism: An in situ hybridization study, Autism Res., 2, 50, 10.1002/aur.62 · DOI
- Yip, 2008, IncreasedGAD67 mRNA expression in cerebellar interneurons in autism: Implications for Purkinje cell dysfunction, J. Neurosci. Res., 86, 525, 10.1002/jnr.21520 · DOI
- Ginsberg, M.R., Rubin, R.A., Falcone, T., Ting, A.H., and Natowicz, M.R. (2012). Brain Transcriptional and Epigenetic Associations with Autism. PLoS ONE, 7. · DOI · Paper page
- Wang, 2012, MicroRNAs in learning, memory, and neurological diseases, Learn. Mem., 19, 359, 10.1101/lm.026492.112 · DOI · Paper page
- Havranek, 2024, Oxytocin, GABA, and dopamine interplay in autism, Endocr. Regul., 58, 105, 10.2478/enr-2024-0012 · DOI
- Bukatova, 2021, Shank3 Deficiency is Associated With Altered Profile of Neurotransmission Markers in Pups and Adult Mice, Neurochem. Res., 46, 3342, 10.1007/s11064-021-03435-6 · DOI
- Yoo, T., Cho, H., Lee, J., Park, H., Yoo, Y.-E., Yang, E., Kim, J.Y., Kim, H., and Kim, E. (2018). GABA Neuronal Deletion of Shank3 Exons 14–16 in Mice Suppresses Striatal Excitatory Synaptic Input and Induces Social and Locomotor Abnormalities. Front. Cell. Neurosci., 12. · DOI · Paper page
- Lisco, G., De Tullio, A., Iovino, M., Disoteo, O., Guastamacchia, E., Giagulli, V.A., and Triggiani, V. (2023). Dopamine in the Regulation of Glucose Homeostasis, Pathogenesis of Type 2 Diabetes, and Chronic Conditions of Impaired Dopamine Activity/Metabolism: Implication for Pathophysiological and Therapeutic Purposes. Biomedicines, 11. · DOI
- Poppi, L.A., Ho-Nguyen, K.T., Shi, A., Daut, C.T., and Tischfield, M.A. (2021). Recurrent Implication of Striatal Cholinergic Interneurons in a Range of Neurodevelopmental, Neurodegenerative, and Neuropsychiatric Disorders. Cells, 10. · DOI
- Lemos, 2019, Striatal Cholinergic Interneurons Are a Novel Target of Corticotropin Releasing Factor, J. Neurosci., 39, 5647, 10.1523/JNEUROSCI.0479-19.2019 · DOI
- Schmidt, 2019, Nucleus accumbens activation is linked to salience in social decision making, Eur. Arch. Psychiatry Clin. Neurosci., 269, 701, 10.1007/s00406-018-0947-6 · DOI
- Walle, 2024, Nucleus accumbens D1- and D2-expressing neurons control the balance between feeding and activity-mediated energy expenditure, Nat. Commun., 15, 2543, 10.1038/s41467-024-46874-9 · DOI
- Bouarab, C., Thompson, B., and Polter, A.M. (2019). VTA GABA Neurons at the Interface of Stress and Reward. Front. Neural Circuits, 13. · DOI · Paper page
- Li, 2019, Role of Descending Dopaminergic Pathways in Pain Modulation, Curr. Neuropharmacol., 17, 1176, 10.2174/1570159X17666190430102531 · DOI
- Deperrois, N., Moiseeva, V., and Gutkin, B. (2019). Minimal Circuit Model of Reward Prediction Error Computations and Effects of Nicotinic Modulations. Front. Neural Circuits, 12. · DOI
- Loonen, 2013, New insights into the mechanism of drug-induced dyskinesia, CNS Spectrums, 18, 15, 10.1017/S1092852912000752 · DOI
- Zinger, 2011, The Involvement of Neuroinflammation and Kynurenine Pathway in Parkinson′ s Disease, Park. Dis., 2011, 716859
- Grillner, 2016, The Basal Ganglia Over 500 Million Years, Curr. Biol., 26, R1088, 10.1016/j.cub.2016.06.041 · DOI · Paper page
- Pretegiani, E., and Optican, L.M. (2017). Eye Movements in Parkinson’s Disease and Inherited Parkinsonian Syndromes. Front. Neurol., 8. · DOI
- Partanen, J., and Achim, K. (2022). Neurons gating behavior—Developmental, molecular and functional features of neurons in the Substantia Nigra pars reticulata. Front. Neurosci., 16. · DOI
- Walter, B.L., and Shaikh, A.G. (2014). Encyclopedia of the Neurological Sciences, Academic Press. [2nd ed.].
- Galtieri, 2017, Pedunculopontine glutamatergic neurons control spike patterning in substantia nigra dopaminergic neurons, eLife, 6, e30352, 10.7554/eLife.30352 · DOI
- Futami, 1995, Glutamatergic and cholinergic inputs from the pedunculopontine tegmental nucleus to dopamine neurons in the substantia nigra pars compacta, Neurosci. Res., 21, 331, 10.1016/0168-0102(94)00869-H · DOI · Paper page
- Collins, 2020, Heterogeneity in striatal dopamine circuits: Form and function in dynamic reward seeking, J. Neurosci. Res., 98, 1046, 10.1002/jnr.24587 · DOI · Paper page
- Skirzewski, 2022, Continuous cholinergic-dopaminergic updating in the nucleus accumbens underlies approaches to reward-predicting cues, Nat. Commun., 13, 7924, 10.1038/s41467-022-35601-x · DOI
- Suzuki, 2021, M1 muscarinic acetylcholine receptor-mediated inhibition of GABA release from striatal medium spiny neurons onto cholinergic interneurons, Eur. J. Neurosci., 53, 796, 10.1111/ejn.15074 · DOI
- Myslivecek, J. (2021). Two Players in the Field: Hierarchical Model of Interaction between the Dopamine and Acetylcholine Signaling Systems in the Striatum. Biomedicines, 9. · DOI
- Coimbra, 2016, Activation of D2 dopamine receptor-expressing neurons in the nucleus accumbens increases motivation, Nat. Commun., 7, 11829, 10.1038/ncomms11829 · DOI · Paper page
- Gittis, 2012, Striatal microcircuitry and movement disorders, Trends Neurosci., 35, 557, 10.1016/j.tins.2012.06.008 · DOI · Paper page
- Gagnon, 2017, Striatal Neurons Expressing D1 and D2 Receptors are Morphologically Distinct and Differently Affected by Dopamine Denervation in Mice, Sci. Rep., 7, 41432, 10.1038/srep41432 · DOI · Paper page
- Lipton, D.M., Gonzales, B.J., and Citri, A. (2019). Dorsal Striatal Circuits for Habits, Compulsions and Addictions. Front. Syst. Neurosci., 13. · DOI · Paper page
- Kwon, H.G., and Jang, S.H. (2014). Differences in neural connectivity between the substantia nigra and ventral tegmental area in the human brain. Front. Hum. Neurosci., 8. · DOI
- Martig, 2011, Ventral tegmental area and substantia nigra neural correlates of spatial learning, Learn. Mem., 18, 260, 10.1101/lm.1895211 · DOI
- Brown, R.E., and McKenna, J.T. (2015). Turning a Negative into a Positive: Ascending GABAergic Control of Cortical Activation and Arousal. Front. Neurol., 6. · DOI
- Vadakkan, 2021, Framework for internal sensation of pleasure using constraints from disparate findings in nucleus accumbens, World J. Psychiatry, 11, 681, 10.5498/wjp.v11.i10.681 · DOI
- Li, 2020, A neuroimaging biomarker for striatal dysfunction in schizophrenia, Nat. Med., 26, 558, 10.1038/s41591-020-0793-8 · DOI · Paper page
- Kosillo, P., and Bateup, H.S. (2021). Dopaminergic Dysregulation in Syndromic Autism Spectrum Disorders: Insights From Genetic Mouse Models. Front. Neural Circuits, 15. · DOI
- Howard, 2017, Dynamic Nigrostriatal Dopamine Biases Action Selection, Neuron, 93, 1436, 10.1016/j.neuron.2017.02.029 · DOI · Paper page
- Uchida, 2018, Multiple Dopamine Systems: Weal and Woe of Dopamine, Cold Spring Harb. Symp. Quant. Biol., 83, 83, 10.1101/sqb.2018.83.037648 · DOI
- Afjei, 2019, A Neural Circuit Mechanism for Encoding Aversive Stimuli in the Mesolimbic Dopamine System, Neuron, 101, 133, 10.1016/j.neuron.2018.11.005 · DOI · Paper page
- Hamid, 2016, Mesolimbic dopamine signals the value of work, Nat. Neurosci., 19, 117, 10.1038/nn.4173 · DOI · Paper page
- Mohebi, 2019, Dissociable dopamine dynamics for learning and motivation, Nature, 570, 65, 10.1038/s41586-019-1235-y · DOI · Paper page
- Bruining, 2020, Measurement of excitation-inhibition ratio in autism spectrum disorder using critical brain dynamics, Sci. Rep., 10, 9195, 10.1038/s41598-020-65500-4 · DOI · Paper page
- Stavropoulos, 2018, Oscillatory rhythm of reward: Anticipation and processing of rewards in children with and without autism, Mol. Autism, 9, 4, 10.1186/s13229-018-0189-5 · DOI
- Romaniuk, 2021, Glutamate and functional connectivity—support for the excitatory-inhibitory imbalance hypothesis in autism spectrum disorders, Psychiatry Res. Neuroimaging, 313, 111302, 10.1016/j.pscychresns.2021.111302 · DOI
- Smolders, 1997, Muscarinic modulation of striatal dopamine, glutamate, and GABA release, as measured with in vivo microdialysis, J. Neurochem., 68, 1942, 10.1046/j.1471-4159.1997.68051942.x · DOI
- Wise, 2009, Roles for nigrostriatal—Not just mesocorticolimbic—Dopamine in reward and addiction, Trends Neurosci., 32, 517, 10.1016/j.tins.2009.06.004 · DOI · Paper page
- Luo, 2016, Dopaminergic Neurons and Brain Reward Pathways, Am. J. Pathol., 186, 478, 10.1016/j.ajpath.2015.09.023 · DOI · Paper page
- Rios, A., Nonomura, S., Kato, S., Yoshida, J., Matsushita, N., Nambu, A., Takada, M., Hira, R., Kobayashi, K., and Sakai, Y. (2023). Reward expectation enhances action-related activity of nigral dopaminergic and two striatal output pathways. Commun. Biol., 6. · DOI
- Hollon, 2021, Nigrostriatal dopamine signals sequence-specific action-outcome prediction errors, Curr. Biol., 31, 5350, 10.1016/j.cub.2021.09.040 · DOI
- Humphrys, 2024, Activation of Multiple G Protein Pathways to Characterize the Five Dopamine Receptor Subtypes Using Bioluminescence Technology, ACS Pharmacol. Transl. Sci., 7, 834, 10.1021/acsptsci.3c00339 · DOI
- Mishra, 2018, Physiological and Functional Basis of Dopamine Receptors and Their Role in Neurogenesis: Possible Implication for Parkinson’s disease, J. Exp. Neurosci., 12, 1179069518779829, 10.1177/1179069518779829 · DOI · Paper page
- Gurevich, 2016, G protein-coupled receptor kinases as regulators of dopamine receptor functions, Pharmacol. Res., 111, 1, 10.1016/j.phrs.2016.05.010 · DOI · Paper page
- García-Domínguez, I., Suárez-Pereira, I., Santiago, M., Pérez-Villegas, E.M., Bravo, L., López-Martín, C., Roca-Ceballos, M.A., García-Revilla, J., Espinosa-Oliva, A.M., and Rodríguez-Gómez, J.A. (2021). Selective deletion of Caspase-3 gene in the dopaminergic system exhibits autistic-like behaviour. Prog. Neuro-Psychopharmacology Biol. Psychiatry, 104. · DOI
- South, 2017, Anxiety and ASD: Current Progress and Ongoing Challenges, J. Autism Dev. Disord., 47, 3679, 10.1007/s10803-017-3322-y · DOI
- Phan, 2021, Engrailed 2 deficiency and chronic stress alter avoidance and motivation behaviors, Behav. Brain Res., 413, 113466, 10.1016/j.bbr.2021.113466 · DOI
- Cannon, 2003, Reward without Dopamine, J. Neurosci., 23, 10827, 10.1523/JNEUROSCI.23-34-10827.2003 · DOI · Paper page
- Robertson, 2016, Reduced GABAergic Action in the Autistic Brain, Curr. Biol., 26, 80, 10.1016/j.cub.2015.11.019 · DOI · Paper page
- Ford, T.C., Nibbs, R., and Crewther, D.P. (2017). Glutamate/GABA+ ratio is associated with the psychosocial domain of autistic and schizotypal traits. PLoS ONE, 12. · DOI
- Fatemi, 2014, Downregulation of GABAA receptor protein subunits α6, β2, δ, ε, γ2, θ, and ρ2 in superior frontal cortex of subjects with autism, J. Autism Dev. Disord., 44, 1833, 10.1007/s10803-014-2078-x · DOI
- Shinohe, 2006, Increased serum levels of glutamate in adult patients with autism, Prog. Neuro-Psychopharmacology Biol. Psychiatry, 30, 1472, 10.1016/j.pnpbp.2006.06.013 · DOI · Paper page
- Said, 2013, Normal binocular rivalry in autism: Implications for the excitation/inhibition imbalance hypothesis, Vis. Res., 77, 59, 10.1016/j.visres.2012.11.002 · DOI · Paper page
- Wang, 2017, Striatopallidal dysfunction underlies repetitive behavior in Shank3-deficient model of autism, J. Clin. Investig., 127, 1978, 10.1172/JCI87997 · DOI · Paper page
- Andersson, 2021, Serotonin transporter availability in adults with autism—A positron emission tomography study, Mol. Psychiatry, 26, 1647, 10.1038/s41380-020-00868-3 · DOI
- Cavalcante, 2017, Modulation of the storage of social recognition memory by neurotransmitter systems in the insular cortex, Behav. Brain Res., 334, 129, 10.1016/j.bbr.2017.07.044 · DOI
- Barkus, E., and Badcock, J.C. (2019). A Transdiagnostic Perspective on Social Anhedonia. Front. Psychiatry, 10. · DOI · Paper page
- Wang, 2020, The role of dopamine in reward-related behavior: Shining new light on an old debate, J. Neurophysiol., 124, 309, 10.1152/jn.00323.2020 · DOI
- Masten, 2011, An fMRI investigation of responses to peer rejection in adolescents with autism spectrum disorders, Dev. Cogn. Neurosci., 1, 260, 10.1016/j.dcn.2011.01.004 · DOI
- Brandenburg, C., Soghomonian, J.-J., Zhang, K., Sulkaj, I., Randolph, B., Kachadoorian, M., and Blatt, G.J. (2020). Increased Dopamine Type 2 Gene Expression in the Dorsal Striatum in Individuals With Autism Spectrum Disorder Suggests Alterations in Indirect Pathway Signaling and Circuitry. Front. Cell. Neurosci., 14. · DOI
- Gerfen, C.R. (2023). Segregation of D1 and D2 dopamine receptors in the striatal direct and indirect pathways: An historical perspective. Front. Synaptic Neurosci., 14. · DOI
- Soghomonian, J.J. (2024). The cortico-striatal circuitry in autism-spectrum disorders: A balancing act. Front. Cell. Neurosci., 17. · DOI
- Girgis, 2016, Preferential binding to dopamine D3 over D2 receptors by cariprazine in patients with schizophrenia using PET with the D3/D2 receptor ligand [11C]-(+)-PHNO, Psychopharmacology, 233, 3503, 10.1007/s00213-016-4382-y · DOI
- Pedrosa, 2021, Effects of Risperidone in Autistic Children and Young Adults: A Systematic Review and Meta-Analysis, Curr. Neuropharmacol., 19, 538, 10.2174/1570159X18666200529151741 · DOI
- Olotu, 2021, Exploring the structural basis and atomistic binding mechanistic of the selective antagonist blockade at D3 dopamine receptor over D2 dopamine receptor, J. Mol. Recognit., 34, e2885, 10.1002/jmr.2885 · DOI
- Hermans, 2023, Towards precision dosing of aripiprazole in children and adolescents with autism spectrum disorder: Linking blood levels to weight gain and effectiveness, Br. J. Clin. Pharmacol., 89, 3026, 10.1111/bcp.15800 · DOI
- Cohen, 2012, Adverse effects of second-generation antipsychotics in children and adolescents: A Bayesian meta-analysis, J. Clin. Psychopharmacol., 32, 309, 10.1097/JCP.0b013e3182549259 · DOI · Paper page
- Lee, A., Choo, H., and Jeon, B. (2022). Serotonin Receptors as Therapeutic Targets for Autism Spectrum Disorder Treatment. Int. J. Mol. Sci., 23. · DOI
- Eissa, N., Venkatachalam, K., Jayaprakash, P., Yuvaraju, P., Falkenstein, M., Stark, H., and Sadek, B. (2022). Experimental Studies Indicate That ST-2223, the Antagonist of Histamine H3 and Dopamine D2/D3 Receptors, Restores Social Deficits and Neurotransmission Dysregulation in Mouse Model of Autism. Pharmaceuticals, 15. · DOI
- Cosi, 2021, Pharmacology profile of F17464, a dopamine D3 receptor preferential antagonist, Eur. J. Pharmacol., 890, 173635, 10.1016/j.ejphar.2020.173635 · DOI
- Venkatachalam, K., Eissa, N., Al Awad, M., Jayaprakash, P., Zhong, S., Stölting, F., Stark, H., and Sadek, B. (2021). The histamine H3R and dopamine D2R/D3R antagonist ST-713 ameliorates autism-like behavioral features in BTBR T+tf/J mice by multiple actions. Biomed. Pharmacother., 138. · DOI
- Matta, 2019, The influence of neuroinflammation in Autism Spectrum Disorder, Brain Behav. Immun., 79, 75, 10.1016/j.bbi.2019.04.037 · DOI · Paper page
- Tamouza, R., Volt, F., Richard, J.-R., Wu, C.-L., Bouassida, J., Boukouaci, W., Lansiaux, P., Cappelli, B., Scigliuolo, G.M., and Rafii, H. (2022). Possible Effect of the use of Mesenchymal Stromal Cells in the Treatment of Autism Spectrum Disorders: A Review. Front. Cell Dev. Biol., 10. · DOI
- Jembrek, 2015, GABA Receptors: Pharmacological Potential and Pitfalls, Curr. Pharm. Des., 21, 4943, 10.2174/1381612821666150914121624 · DOI · Paper page
- Cogram, P., Deacon, R.M.J., Warner-Schmidt, J.L., von Schimmelmann, M.J., Abrahams, B.S., and During, M.J. (2019). Gaboxadol Normalizes Behavioral Abnormalities in a Mouse Model of Fragile X Syndrome. Front. Behav. Neurosci., 13. · DOI
- 2021, The The dopamine hypothesis of autism spectrum disorder revisited: Current status and future prospects, Dev. Neurosci., 43, 73, 10.1159/000515751 · DOI
- Kramer, 2018, Combinatorial Expression of Grp and Neurod6 Defines Dopamine Neuron Populations with Distinct Projection Patterns and Disease Vulnerability, eneuro, 5, ENEURO.0152-18.2018, 10.1523/ENEURO.0152-18.2018 · DOI · Paper page
- Blum, 2018, The Benefits of Genetic Addiction Risk Score (GARS™) Testing in Substance Use Disorder (SUD), Int. J. Genom. Data Min., 2018, 115
- Blum, 2023, Evidence for the DRD2 Gene as a Determinant of Reward Deficiency Syndrome (RDS), Clin. Exp. Psychol., 9, 8
- Dennen, C.A., Blum, K., Bowirrat, A., Thanos, P.K., Elman, I., Ceccanti, M., Badgaiyan, R.D., McLaughlin, T., Gupta, A., and Bajaj, A. (2022). Genetic Addiction Risk Severity Assessment Identifies Polymorphic Reward Genes as Antecedents to Reward Deficiency Syndrome (RDS) Hypodopaminergia’s Effect on Addictive and Non-Addictive Behaviors in a Nuclear Family. J. Pers. Med., 12. · DOI
- Jensen, 2022, Modern Biomarkers for Autism Spectrum Disorder: Future Directions, Mol. Diagn. Ther., 26, 483, 10.1007/s40291-022-00600-7 · DOI
- Santarone, M.E., Zambrano, S., Zanotta, N., Mani, E., Minghetti, S., Pozzi, M., Villa, L., Molteni, M., and Zucca, C. (2023). EEG Features in Autism Spectrum Disorder: A Retrospective Analysis in a Cohort of Preschool Children. Brain Sci., 13. · DOI
- Ayoub, M.J., Keegan, L., Tager-Flusberg, H., and Gill, S.V. (2022). Neuroimaging Techniques as Descriptive and Diagnostic Tools for Infants at Risk for Autism Spectrum Disorder: A Systematic Review. Brain Sci., 12. · DOI
Cited by
Ramme, A., Zachow, M., Habelt, B., Vojtechova, I., Petrasek, T., Waltereit, R., & Bernhardt, N. (2025) · Behavioral and Brain Functions · doi:10.1186/s12993-025-00284-z · Cited by 1
Metadata
- Authors
- Blum, K., Bowirrat, A., Sunder, K., Thanos, P. K., Hanna, C., Gold, M. S., Dennen, C. A., Elman, I., Murphy, K. T., & Makale, M. T.
- Venue
- Brain Sciences
- Publisher
- MDPI AG
- Published
- 2024-07-22
- Volume
- 14
- Issue
- 7
- Pages
- 733
- ISSN
- 2076-3425
- Cited by
- 47
- References
- 51
- Language
- en
- Funders
- PeakLogic Inc.
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dopamine Dysregulation in Reward and Autism Spectrum Disorder. https://app.cochat.ai/papers/10.3390/brainsci14070733
- The paper
- Blum, K., Bowirrat, A., Sunder, K., Thanos, P. K., Hanna, C., Gold, M. S., Dennen, C. A., Elman, I., Murphy, K. T., & Makale, M. T. (2024). Dopamine Dysregulation in Reward and Autism Spectrum Disorder. Brain Sciences. https://doi.org/10.3390/brainsci14070733
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.